We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
-17.49%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$6.07M
(-2.8%)
Cap. Flow
+$50.8M
Cap. Flow
% of AUM
23.88%
Top 10 Holdings %
Top 10 Hldgs %
56.19%
Holding
53
New
16
Increased
15
Reduced
11
Closed
9
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$13.7M |
| 2 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$7.82M |
| 3 |
Cue Biopharma
CUE
|
+$6.7M |
| 4 |
Direxion Daily Small Cap Bear 3x ETF
TZA
|
+$6.06M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$5.96M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
+$8.99M |
| 2 |
United Therapeutics
UTHR
|
+$6.39M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$6.02M |
| 4 |
Zimmer Biomet
ZBH
|
+$3.38M |
| 5 |
Envista
NVST
|
+$2.74M |
Sector Composition
| 1 | Healthcare | 91.35% |
| 2 | Technology | 2.63% |
| 3 | Energy | 2.3% |
| 4 | Industrials | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Organogenesis Holdings
ORGO
$319M
| $2.17M | 1.02% |
672,275
+54,439
| +9% | +$233K |
|
27
Evolus
EOLS
$389M
| $2.13M | 1% |
514,206
+277,267
| +117% | +$2.35M |
|
|
28
BioMarin Pharmaceuticals
BMRN
$11.4B
| $1.94M | 0.91% |
22,900
-69,837
| -75% | -$6.02M |
|
29
Immunovant
IMVT
$8.14B
| $1.89M | 0.89% |
121,429
-103,273
| -46% | -$1.55M |
|
30
Establishment Labs
ESTA
$2.66B
| $1.83M | 0.86% |
+126,658
| New | +$2.8M |
|
31
Gyre Therapeutics
GYRE
$731M
| $1.67M | 0.79% |
51,053
-1,200
| -2% | -$55.1K |
|
32
AbbVie
ABBV
$436B
| $1.22M | 0.57% |
+16,030
| New | +$1.37M |
|
33
AnaptysBio
ANAB
$1.68B
| $1.12M | 0.52% |
78,976
-155,847
| -66% | -$2.36M |
|
|
34
Envista
NVST
$4.33B
| $867K | 0.41% |
58,000
-107,000
| -65% | -$2.74M |
|
35
Ligand Pharmaceuticals
LGND
$5.9B
| $836K | 0.39% |
+18,435
| New | +$1.04M |
|
36
HCA Healthcare
HCA
$83.6B
| $829K | 0.39% |
+9,223
| New | +$1.19M |
|
|
APEN
37
DELISTED
Apollo Endosurgery, Inc.
APEN
| $648K | 0.3% |
337,262
+177,926
| +112% | +$467K |
|
38
Insperity
NSP
$1.81B
| $481K | 0.23% |
+12,900
| New | +$915K |
|
|
KZR
39
DELISTED
Kezar Life Sciences
KZR
| $421K | 0.2% |
9,662
-22,338
| -70% | -$909K |
|
|
MITO
40
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
| $417K | 0.2% |
+336,167
| New | +$748K |
|
41
Tenet Healthcare
THC
$16.5B
| $301K | 0.14% |
+20,918
| New | +$600K |
|
42
Milestone Pharmaceuticals
MIST
$157M
| $77K | 0.04% |
41,592
+3,111
| +8% | +$53.9K |
|
|
ALLK
43
DELISTED
Allakos
ALLK
| – | – |
0
| – | – |
|
44
Axsome Therapeutics
AXSM
$12.1B
| – | – |
0
| – | – |
|
45
Bristol-Myers Squibb
BMY
$120B
| – | – |
-8,100
| Closed | -$520K |
|
46
Evolent Health
EVH
$648M
| – | – |
-279,390
| Closed | -$2.53M |
|
47
TriNet
TNET
$2.63B
| – | – |
-28,104
| Closed | -$1.59M |
|
|
RCM
48
DELISTED
R1 RCM Inc. Common Stock
RCM
| – | – |
-200,000
| Closed | -$2.6M |
|
|
PRTK
49
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| – | – |
-450,000
| Closed | -$1.81M |
|
|
MTEM
50
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
-10,726
| Closed | -$2.25M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA